Cargando…
Prevalence of severe asthma according to the drug regulatory agency perspective: An Italian experience
Autores principales: | Vianello, A., Caminati, M., Andretta, M., Menti, A.M., Tognella, S., Senna, G., Degli Esposti, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517682/ https://www.ncbi.nlm.nih.gov/pubmed/31193146 http://dx.doi.org/10.1016/j.waojou.2019.100032 |
Ejemplares similares
-
Low adherence to inhaled corticosteroids/long-acting β(2)-agonists and biologic treatment in severe asthmatics
por: Caminati, Marco, et al.
Publicado: (2020) -
Treatment Pattern Analysis and Health-care Resource Consumption on Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Biological Drugs in a Northern Italian Region
por: Perrone, Valentina, et al.
Publicado: (2020) -
Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience
por: Caminati, M., et al.
Publicado: (2016) -
Trends and determinants of Emergency Room admissions for asthma: A retrospective evaluation in Northeast Italy
por: Caminati, Marco, et al.
Publicado: (2019) -
Clinical Characteristics And Health Care Resources In Patients Treated With Oral Anticoagulants: Evidences From Italian Administrative Databases
por: Degli Esposti, L, et al.
Publicado: (2019)